Bronstein, Gewirtz & Grossman, LLC Is Investigating Larimar Therapeutics, Inc. (LRMR) And Encourages Investors to Connect
NEW YORK CITY, NY / ACCESS Newswire / October 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Larimar Therapeutics, Inc. ("Larimar" or "the Company") (NASDAQ:LRMR). Investors who purchased Larimar securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/LRMR. […]